SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
15925813
Source:
http://linkedlifedata.com/resource/pubmed/id/15925813
Search
Subject
(
36
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0001554
,
umls-concept:C1273870
pubmed:issue
6
pubmed:dateCreated
2005-5-31
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/15925813-15683818
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/100957246
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antiemetics
,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Histamine H1 Antagonists
,
http://linkedlifedata.com/resource/pubmed/chemical/Mianserin
,
http://linkedlifedata.com/resource/pubmed/chemical/mirtazapine
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1470-2045
pubmed:author
pubmed-author:RajiMukaila AMA
pubmed:issnType
Print
pubmed:volume
6
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
357
pubmed:dateRevised
2006-7-7
pubmed:meshHeading
pubmed-meshheading:15925813-Antiemetics
,
pubmed-meshheading:15925813-Antineoplastic Agents
,
pubmed-meshheading:15925813-Histamine H1 Antagonists
,
pubmed-meshheading:15925813-Humans
,
pubmed-meshheading:15925813-Mianserin
,
pubmed-meshheading:15925813-Nausea
,
pubmed-meshheading:15925813-Neoplasms
,
pubmed-meshheading:15925813-Vomiting
pubmed:year
2005
pubmed:articleTitle
Management of chemotherapy-induced side-effects.
pubmed:publicationType
Letter
,
Comment